MAETZOLD DEREK J sold CSTL

February 4, 2026 · Form 4 insider transaction

MAETZOLD DEREK J sold 171 shares of Castle Biosciences, Inc. at $38.61 per share, a transaction worth $6.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
171
Price
$38.61
Total value
$6.6K
Role
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 4, 2026
Filing dateFebruary 5, 2026
Shares owned after83,698
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 8, 2025.; This transaction was executed in multiple trades at prices ranging from $38.520 to $38.885, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

View the original Form 4 on SEC EDGAR
MAETZOLD DEREK J sold CSTL: February 4, 2026 | Insider Trading Screener